Cooper Price to Free Cash Flow Ratio 2010-2024 | COO
Historical price to free cash flow ratio values for Cooper (COO) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Cooper Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2024-11-06 |
103.78 |
|
109.70 |
| 2024-07-31 |
93.33 |
$0.95 |
98.66 |
| 2024-04-30 |
89.06 |
$0.61 |
145.38 |
| 2024-01-31 |
23.31 |
$0.68 |
34.21 |
| 2023-10-31 |
19.48 |
$1.08 |
18.05 |
| 2023-07-31 |
24.45 |
$1.11 |
22.09 |
| 2023-04-30 |
23.84 |
$1.95 |
12.25 |
| 2023-01-31 |
21.81 |
$2.14 |
10.19 |
| 2022-10-31 |
17.08 |
$2.27 |
7.54 |
| 2022-07-31 |
20.43 |
$2.64 |
7.74 |
| 2022-04-30 |
22.56 |
$2.44 |
9.23 |
| 2022-01-31 |
24.89 |
$2.72 |
9.17 |
| 2021-10-31 |
26.05 |
$2.63 |
9.90 |
| 2021-07-31 |
26.35 |
$2.64 |
9.97 |
| 2021-04-30 |
25.67 |
$2.08 |
12.33 |
| 2021-01-31 |
22.74 |
$1.04 |
21.77 |
| 2020-10-31 |
19.93 |
$0.89 |
22.44 |
| 2020-07-31 |
17.67 |
$0.91 |
19.50 |
| 2020-04-30 |
17.91 |
$1.17 |
15.33 |
| 2020-01-31 |
21.67 |
$2.30 |
9.43 |
| 2019-10-31 |
18.18 |
$2.11 |
8.63 |
| 2019-07-31 |
21.07 |
$2.50 |
8.43 |
| 2019-04-30 |
18.11 |
$2.81 |
6.43 |
| 2019-01-31 |
17.41 |
$2.63 |
6.61 |
| 2018-10-31 |
16.13 |
$2.39 |
6.75 |
| 2018-07-31 |
16.27 |
$2.26 |
7.19 |
| 2018-04-30 |
14.28 |
$1.93 |
7.41 |
| 2018-01-31 |
15.28 |
$1.82 |
8.40 |
| 2017-10-31 |
15.00 |
$2.35 |
6.38 |
| 2017-07-31 |
15.22 |
$2.31 |
6.58 |
| 2017-04-30 |
12.51 |
$2.23 |
5.61 |
| 2017-01-31 |
11.52 |
$2.00 |
5.77 |
| 2016-10-31 |
10.99 |
$1.82 |
6.03 |
| 2016-07-31 |
11.39 |
$1.25 |
9.11 |
| 2016-04-30 |
9.55 |
$0.90 |
10.59 |
| 2016-01-31 |
8.18 |
$0.90 |
9.06 |
| 2015-10-31 |
9.51 |
$0.75 |
12.65 |
| 2015-07-31 |
11.04 |
$0.99 |
11.21 |
| 2015-04-30 |
11.11 |
$1.10 |
10.09 |
| 2015-01-31 |
9.83 |
$1.14 |
8.60 |
| 2014-10-31 |
10.22 |
$1.11 |
9.24 |
| 2014-07-31 |
10.03 |
$1.03 |
9.71 |
| 2014-04-30 |
8.22 |
$1.09 |
7.55 |
| 2014-01-31 |
7.75 |
$1.14 |
6.78 |
| 2013-10-31 |
8.05 |
$1.20 |
6.73 |
| 2013-07-31 |
7.94 |
$1.22 |
6.50 |
| 2013-04-30 |
6.88 |
$1.17 |
5.87 |
| 2013-01-31 |
6.32 |
$1.08 |
5.87 |
| 2012-10-31 |
5.98 |
$1.10 |
5.46 |
| 2012-07-31 |
4.69 |
$1.09 |
4.29 |
| 2012-04-30 |
5.49 |
$1.16 |
4.72 |
| 2012-01-31 |
4.49 |
$1.08 |
4.15 |
| 2011-10-31 |
4.31 |
$1.20 |
3.58 |
| 2011-07-31 |
4.76 |
$0.96 |
4.98 |
| 2011-04-30 |
4.66 |
$0.93 |
5.02 |
| 2011-01-31 |
3.57 |
$1.04 |
3.43 |
| 2010-10-31 |
3.07 |
$1.04 |
2.94 |
| 2010-07-31 |
2.42 |
$1.20 |
2.02 |
| 2010-04-30 |
2.42 |
$1.19 |
2.03 |
| 2010-01-31 |
2.20 |
$1.00 |
2.20 |
| 2009-10-31 |
1.74 |
$0.71 |
2.45 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$20.668B |
$3.593B |
|
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
|
